A detailed history of Northeast Financial Consultants Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Northeast Financial Consultants Inc holds 44,175 shares of ZTS stock, worth $7.31 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
44,175
Previous 44,156 0.04%
Holding current value
$7.31 Million
Previous $7.65 Million 12.75%
% of portfolio
0.38%
Previous 0.36%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$172.58 - $196.48 $3,279 - $3,733
19 Added 0.04%
44,175 $8.63 Million
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $100,283 - $115,662
600 Added 1.38%
44,156 $7.68 Million
Q2 2023

Aug 08, 2023

BUY
$160.94 - $186.23 $183,954 - $212,860
1,143 Added 2.69%
43,556 $7.5 Million
Q1 2023

May 15, 2023

BUY
$145.48 - $175.02 $47,571 - $57,231
327 Added 0.78%
42,413 $7.06 Million
Q3 2022

Nov 15, 2022

SELL
$148.29 - $182.55 $87,935 - $108,252
-593 Reduced 1.39%
42,086 $6.24 Million
Q2 2022

Aug 12, 2022

SELL
$155.97 - $200.09 $5,458 - $7,003
-35 Reduced 0.08%
42,679 $7.34 Million
Q1 2022

May 12, 2022

BUY
$181.39 - $234.03 $8,525 - $10,999
47 Added 0.11%
42,714 $8.06 Million
Q2 2021

Aug 16, 2021

BUY
$155.9 - $187.99 $2.52 Million - $3.04 Million
16,175 Added 61.06%
42,667 $7.95 Million
Q1 2021

May 13, 2021

BUY
$144.0 - $169.39 $409,536 - $481,745
2,844 Added 12.03%
26,492 $4.17 Million
Q2 2020

Jul 30, 2020

BUY
$111.92 - $142.53 $414,551 - $527,931
3,704 Added 18.57%
23,648 $3.24 Million
Q1 2020

May 13, 2020

SELL
$92.66 - $144.94 $5,374 - $8,406
-58 Reduced 0.29%
19,944 $2.35 Million
Q4 2019

Feb 14, 2020

SELL
$116.25 - $133.25 $38,130 - $43,706
-328 Reduced 1.61%
20,002 $2.65 Million
Q2 2019

Aug 09, 2019

SELL
$97.98 - $114.28 $9,993 - $11,656
-102 Reduced 0.5%
20,330 $2.31 Million
Q1 2019

May 14, 2019

BUY
$81.56 - $100.67 $347,608 - $429,055
4,262 Added 26.36%
20,432 $2.06 Million
Q4 2018

Feb 12, 2019

BUY
$79.28 - $95.27 $873,269 - $1.05 Million
11,015 Added 213.68%
16,170 $1.38 Million
Q3 2018

Nov 08, 2018

SELL
$83.5 - $93.23 $677,686 - $756,654
-8,116 Reduced 61.16%
5,155 $471,000
Q2 2018

Jul 27, 2018

BUY
$79.9 - $89.2 $301,302 - $336,373
3,771 Added 39.69%
13,271 $1.13 Million
Q1 2018

Apr 19, 2018

SELL
$71.51 - $84.69 $3,289 - $3,895
-46 Reduced 0.48%
9,500 $793,000
Q4 2017

Feb 14, 2018

BUY
$63.24 - $72.8 $2,909 - $3,348
46 Added 0.48%
9,546 $687,000
Q3 2017

Nov 13, 2017

BUY
$59.73 - $65.4 $567,435 - $621,300
9,500
9,500 $606,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Northeast Financial Consultants Inc Portfolio

Follow Northeast Financial Consultants Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.